Combigene AB (COMBI) — Cash Flow-to-Debt Ratio
Combigene AB (COMBI) has a Cash Flow-to-Debt Ratio of -1.45x as of December 2024, meaning its operating cash flow of Skr-6.23 Million could theoretically repay -1% of its total liabilities (Skr4.30 Million) in one year. Check total reinvestment intensity of Combigene AB to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Combigene AB Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Combigene AB across 13 annual periods. Also explore Combigene AB asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Combigene AB (2012–2024)
Year-by-year debt coverage analysis for Combigene AB. For market capitalisation and broader financial context, see COMBI stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -6.96x | Skr-29.95 Million | Skr4.30 Million | ▲ +5.3% |
| 2023 | -7.35x | Skr-30.56 Million | Skr4.16 Million | ▼ -169.1% |
| 2022 | -2.73x | Skr-16.67 Million | Skr6.10 Million | ▼ -198.1% |
| 2021 | 2.78x | Skr22.11 Million | Skr7.94 Million | ▲ +158.0% |
| 2020 | -4.80x | Skr-38.35 Million | Skr7.98 Million | ▼ -422.9% |
| 2019 | -0.92x | Skr-21.60 Million | Skr23.51 Million | ▼ -6018.6% |
| 2018 | 0.02x | Skr227.60K | Skr14.66 Million | ▲ +100.3% |
| 2017 | -5.86x | Skr-9.53 Million | Skr1.63 Million | ▲ +46.2% |
| 2016 | -10.88x | Skr-8.81 Million | Skr809.66K | ▼ -19.7% |
| 2015 | -9.09x | Skr-6.29 Million | Skr691.73K | ▼ -752.1% |
| 2014 | -1.07x | Skr-620.67K | Skr582.04K | ▲ +83.9% |
| 2013 | -6.64x | Skr-272.15K | Skr40.98K | ▼ -3426.4% |
| 2012 | 0.20x | Skr59.21K | Skr296.58K | — |